Literature DB >> 19064001

The immunological potential of galectin-1 and -3.

Amy Dhirapong1, Ana Lleo, Patrick Leung, M Eric Gershwin, Fu-Tong Liu.   

Abstract

A family of beta-galactosides-binding proteins, called galectins, have recently emerged as novel molecules with immunoregulatory functions. These proteins are expressed in both inflammatory and non-inflammatory cells including monocytes, macrophages, dendritic cells, mast cells, and B and T cells, giving a broad spectrum of involvement in the immune response. Galectins are uniquely capable of acting both intracellularly and extracellularly, affecting such processes as cell adhesion, signaling, proliferation, differentiation, and apoptosis. Different members of this family have been shown to modulate several pathological processes such as allergic reactions, autoimmunity, and tumor invasion. Therefore, understanding the role of galectins in achieving appropriate proliferative and effector responses to antigens will yield important insights to autoimmune diseases and delineate novel strategies for disease intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064001     DOI: 10.1016/j.autrev.2008.11.009

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  39 in total

1.  IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells.

Authors:  Fang Zhou; Bogoljub Ciric; Hongmei Li; Yaping Yan; Ke Li; Melissa Cullimore; Elisabetta Lauretti; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2012-05-23       Impact factor: 5.532

2.  The thymus microenvironment in regulating thymocyte differentiation.

Authors:  Jacy Gameiro; Patrícia Nagib; Liana Verinaud
Journal:  Cell Adh Migr       Date:  2010-07-15       Impact factor: 3.405

3.  A contemporary update on scleroderma.

Authors:  Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

4.  New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling.

Authors:  Monika Bambouskova; Iva Polakovicova; Ivana Halova; Gautam Goel; Lubica Draberova; Viktor Bugajev; Aivi Doan; Pavol Utekal; Agnes Gardet; Ramnik J Xavier; Petr Draber
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

5.  Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior.

Authors:  Florence Lefranc; Véronique Mathieu; Robert Kiss
Journal:  World J Biol Chem       Date:  2011-09-26

6.  Galectins in hematological malignancies.

Authors:  Yves St-Pierre
Journal:  Am J Blood Res       Date:  2011-09-07

7.  Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Authors:  Marie Duhamel; Mélanie Rose; Franck Rodet; Adriana Natalia Murgoci; Lea Zografidou; Anne Régnier-Vigouroux; Fabien Vanden Abeele; Firas Kobeissy; Serge Nataf; Laurent Pays; Maxence Wisztorski; Dasa Cizkova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2018-03-12       Impact factor: 5.911

8.  Structural aspects of binding of α-linked digalactosides to human galectin-1.

Authors:  Michelle C Miller; João P Ribeiro; Virginia Roldós; Sonsoles Martín-Santamaría; F Javier Cañada; Irina A Nesmelova; Sabine André; Mabel Pang; Anatole A Klyosov; Linda G Baum; Jesús Jiménez-Barbero; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Glycobiology       Date:  2011-06-28       Impact factor: 4.313

9.  Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo.

Authors:  Joy X Jiang; Xiangling Chen; Daniel K Hsu; Kornelia Baghy; Nobuko Serizawa; Fiona Scott; Yoshikazu Takada; Yoko Takada; Hiroo Fukada; Jenny Chen; Sridevi Devaraj; Roger Adamson; Fu-Tong Liu; Natalie J Török
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-08       Impact factor: 4.052

Review 10.  Damage-associated molecular patterns and their receptors in upper airway pathologies.

Authors:  Koen Van Crombruggen; Fenila Jacob; Nan Zhang; Claus Bachert
Journal:  Cell Mol Life Sci       Date:  2013-05-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.